Drug Profile
Polidocanol - 10xBio
Alternative Names: 10XB 101Latest Information Update: 18 Mar 2024
Price :
$50
*
At a glance
- Originator 10xBio
- Class Obesity therapies; Polyethylene glycols; Sclerosants; Small molecules; Vascular disorder therapies
- Mechanism of Action Endothelial cell modulators; Vascular disrupting agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Obesity